Optimizing drug development and use in patients with kidney disease: opportunities, innovations, and challenges.
作者： Marc Pfister , Thomas D. Nolin , Vikram Arya
关键词: Pharmacology 、 Intensive care medicine 、 In patient 、 Medicine 、 Drug development 、 Kidney disease
摘要:
jclinpharm.org参考文章(15)
Sudharshan Hariharan, Rajanikanth Madabushi, Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011415527
Athena F. Zuppa, Understanding renal replacement therapy and dosing of drugs in pediatric patients with kidney disease. The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011415413
Jessica L. Steffl, William Bennett, Ali J. Olyaei, The Old and New Methods of Assessing Kidney Function The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011420260
Rachel Fisseli, Gerald Schulman, Marc Pfister, Liping Zhang, Adriana M. Hung, Novel Dialysis Modalities: Do We Need New Metrics to Optimize Treatment? The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011414576
Matthew M. Riggs, Mark C. Peterson, Marc R. Gastonguay, Multiscale Physiology‐Based Modeling of Mineral Bone Disorder in Patients With Impaired Kidney Function The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011412967
Lei Zhang, Nancy Xu, Shen Xiao, Vikram Arya, Ping Zhao, Lawrence J. Lesko, Shiew‐Mei Huang, Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease. The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011415410
Marcus M. Reidenberg, Early Research on Renal Function and Drug Action The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011413587
Melanie S. Joy, Impact of glomerular kidney diseases on the clearance of drugs. The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011413895
Bernd Meibohm, Honghui Zhou, Characterizing the impact of renal impairment on the clinical pharmacology of biologics. The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011413894
Liping Zhang, David W. Boulton, Marc Pfister, A pharmacometric approach to quantify the impact of chronic kidney disease and hemodialysis on systemic drug exposure: application to saxagliptin. The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011415627